Options Brief: Pharmacyclics Inc. (PCYC)

Shares of Pharmacyclics Inc. PCYC are higher on the session by 6.44%, trading at $7.11. Overall put volume is now running at 17.44x the daily average, with 0% of all puts traded being purchases on the offer. 7,500 contracts have traded on the session so far. Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases.